Is an electronic signature legally valid?

Yes. Electronic signatures are legally valid for most interstate and intrastate transactions under the ESIGN Act (15 U.S.C. §7001) and state UETA statutes, provided intent, consent, attribution, and record retention requirements are met.

How should PHI be protected when submitting?

Handle protected health information in compliance with HIPAA. Use a vendor that supports HIPAA and signs a Business Associate Agreement; retain access logs and limit recipients to authorized public health or internal staff.

Who is authorized to sign the statement?

A clinically responsible party or designated administrative officer typically signs. Authority should be defined by facility policy; document the signer role, printed name, and contact information for verification.

When is notarization or RON required?

Notarization is rarely required for routine incident reporting but may be requested for formal certifications. RON availability and acceptance vary by state; consult the state notary commission for specific rules.

How long must the statement be retained?

Retain records according to applicable laws. HIPAA-regulated documents should be kept for six years from creation or last effective date (45 CFR §164.530(j)); other statutes may require different periods.

What if I discover an error after signing?

Correct errors using an amended statement that references the original signed document. Preserve the original, include an auditable amendment, and notify public health or legal counsel if the correction affects reporting.

Electronic Signature
Templates
Healthcare
Healthcare Bioterrorism Statement

Healthcare Bioterrorism Statement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Bioterrorism Statement

Purpose: This form documents patient disclosures and acknowledgments related to potential exposure to agents of biological origin, and authorizes facility action consistent with applicable public health reporting requirements. The facility may collect specimens, perform diagnostic testing, and disclose necessary health information to public health authorities if indicated by clinical findings or patient disclosures.

Patient Information

Full legal name

Date of birth: Gender: Phone:

Address Emergency contact

Insurance Information

Insurance provider

Policy number

Group number

Subscriber name

Relevant Medical History

Current medications Known allergies (including drug and environmental) Prior surgeries or hospitalizations Chronic medical conditions

Bioterrorism Exposure Screening

Please check each item that applies. Checking indicates a positive response for that item.

Traveled internationally or to an area with unusual outbreaks within the last 30 days

Close contact with a person known or suspected to have an unusual or severe infectious illness

Occupational exposure to biological agents or laboratory work with bacterial, viral, or toxin agents

Known or suspected exposure to an unknown powder, aerosol, or biological material

Presence of unexplained skin lesions, necrotic lesions, or sudden rash

Sudden onset of fever with respiratory distress, severe systemic illness, or shock

If any item above is checked, describe circumstances and timeline

Authorizations and Acknowledgments

I acknowledge that the facility may perform diagnostic testing, collect specimens, and implement infection control measures if my history, symptoms, or clinical evaluation indicate possible exposure to a biological agent. I understand that reporting certain conditions and results to public health authorities is required by law and that the facility will disclose the minimum necessary information to appropriate local, state, or federal public health agencies.

I authorize the facility to release my medical information, laboratory results, and specimens to public health authorities, law enforcement, and other entities as required for investigation and response to suspected biological incidents. I authorize necessary diagnostic testing for agents of biological origin, including but not limited to bacterial, viral, and toxin assays, and I understand that testing may include specimen shipment to designated reference laboratories.

I understand that this authorization is voluntary to the extent permitted by law; however, if testing or reporting is required by public health law, I may not be able to withhold information or testing. I understand that I may revoke this authorization in writing at any time except to the extent that action has already been taken in reliance on this authorization.

I certify that, to the best of my knowledge, the information provided on this form is true and complete. I understand that knowingly providing false or misleading information related to a public health investigation may subject me to civil or criminal penalties under applicable law.

Consent to testing and disclosure (check to consent)

I consent to diagnostic testing and disclosure as described above

Acknowledgment of privacy disclosure to public health (check to acknowledge)

I acknowledge that my identifiable health information may be disclosed to public health authorities as required

Authorization effective date and expiration

Effective date: Expiration date (if any):

Facility Use Only

Clinician assessment

Certification and Signature

By signing below, I certify that I have read and understood the statements above and that the information I have provided is accurate to the best of my knowledge. If signing as legal guardian or authorized representative, I certify that I have authority to execute this form on behalf of the patient.

Patient Printed Name:

Signature:

Date:

Relationship to patient (if signing on behalf of patient):

What the Healthcare Bioterrorism Statement Covers

The Healthcare Bioterrorism Statement is an attestation document used by healthcare providers and institutions to record suspected or confirmed bioterrorism-related incidents, the steps taken in response, and the identities of involved parties. It documents exposure risk, timing, location, clinical findings, and chain-of-custody information for reporting to public health authorities and for internal incident review. When executed electronically, the statement can be signed under federal ESIGN and state UETA/ESRA frameworks and must be handled in accordance with privacy laws such as HIPAA.

Why this statement matters for healthcare operations

A clear Healthcare Bioterrorism Statement creates a consistent record for public health reporting, clinical response, and legal review while supporting auditability and secure retention.

Primary users and who completes the statement

Typical users include clinical leads and administrative staff responsible for incident reporting and compliance.

Hospital infection control teams and epidemiologists who collect clinical and exposure details for internal review and public health reporting.
Emergency department clinicians and attending physicians who document initial clinical observations and patient risk factors at presentation.
Compliance officers and risk managers who verify signatures, retention, and secure distribution to public health agencies.

The form is also used by public health liaisons and legal teams for follow-up, investigation, and recordkeeping.

Who signs and certifies the statement

Chief Medical Officer

The CMO or delegated clinical lead certifies the accuracy of clinical findings and institutional response. They confirm that the incident description and exposure assessment reflect available clinical data and authorize submission to public health authorities.

Infection Control Nurse

An infection control professional typically completes incident-level details, documents exposure pathways, and records immediate mitigation actions. Their entry provides the operational timeline used in public health follow-up and internal incident review.

Required data elements at a glance

Patient Identifier: Name, DOB, MRN

Incident Details: Date, time, location

Exposure Level: Suspected, confirmed, unknown

Clinical Findings: Signs, symptoms, lab notes

Reporting Party: Name and contact

Chain of Custody: Specimen handling notes

Step-by-step: filling out the Healthcare Bioterrorism Statement

Follow these sequential steps to complete, authenticate, and submit the statement while preserving an auditable record.

01

Gather information: Collect patient identifiers, timeline, exposure details, and laboratory results.
02

Complete fields: Enter incident date, location, clinical notes, and exposure assessment accurately.
03

Authenticate signer: Use appropriate signer authentication (email, SMS OTP, or stronger) and capture consent.
04

Submit and archive: Send to public health and retain an auditable copy in secure records.

Typical eSubmission configuration for online completion

Configure the digital workflow to enforce authentication, routing, and retention consistent with legal and clinical requirements.

Field	Configuration
Authentication Method	Email link + SMS one-time passcode
Retention Setting	Automatic 6-year retention with access controls
Recipient Routing	Primary public health + internal risk team
Audit Trail	Capture IP address, timestamp, signer actions

How electronic submission usually flows

A concise overview of the electronic signing and submission pathway for the statement.

Upload document: Provider uploads completed statement template to the platform.
Assign signers: Designate clinical certifier and compliance reviewer.
Authenticate: Signer verifies identity via chosen method.
Submit and notify: System sends copies to public health and archives the record.

Platform considerations for secure eSubmission

Choose a platform that supports secure formats, audit trails, and the integrations you need for routing and retention.

Supported formats: PDF, DOCX, and signed PDF/A
Integrations: Microsoft 365, Google Workspace, NetSuite
Authentication options: Email, SMS OTP, KBA, SSO

Typical timing and reporting windows to consider

Deadlines vary by jurisdiction and incident severity; use local public health rules as the authoritative source.

Immediate internal notification:

Notify internal incident response teams as soon as an event is suspected.

24-hour reporting window:

Many jurisdictions expect initial notification by phone or secure portal within 24 hours.

72-hour detailed report:

Follow up with a detailed written report and supporting lab results within 72 hours where required.

Retention effective date:

Retention generally begins on creation or submission date of the signed statement.

Periodic review schedule:

Review incident records during after-action and quarterly compliance audits.

Key milestones after an incident report is filed

A sequential view of the principal stages from initial report through archival and review.

01

Report Filed

Record submitted and signed by clinical certifier immediately after incident confirmation.

02

Public Health Notification

Primary notification transmitted to the appropriate state or local public health agency within jurisdictional timelines.

03

Specimen Transfer

Samples dispatched to designated labs with chain-of-custody documentation intact.

04

After-Action Review

Conduct internal review to evaluate response, update procedures, and record lessons learned.

Regulatory and operational risks of incomplete or incorrect statements

Regulatory Fines: Potential civil penalties

HIPAA Violations: Breach fines and corrective action

Delayed Response: Slower public health intervention

Legal Liability: Civil exposure for negligence

Data Inaccuracy: Misguided containment efforts

Reputational Harm: Loss of public trust

Common preparation and submission mistakes to avoid

Leaving key fields blank or using vague descriptions which impede epidemiologic investigation and slow public health response.
Using inconsistent date or time formats that create ambiguity for exposure windows and laboratory correlation.
Failing to authenticate the signer properly, which can invalidate the submission under ESIGN/UETA for interstate transactions.
Not preserving the audit trail or chain-of-custody, undermining evidence needed for lab confirmation and legal review.

Real-world scenarios for using the statement

Two concise examples illustrate common uses: initial clinical reporting and multi-agency incident coordination.

Clinical Incident Report

A patient presents with unusual respiratory symptoms after a public gathering; clinicians document onset and specimen collection

Lab sample sent for confirmatory testing
The signed statement is submitted to the county health department and retained in the patient record for six years under HIPAA.

Multi-Agency Coordination

A suspicious environmental exposure is reported at a community event; hospital documents exposure pathway and affected individuals

Local public health and emergency management are notified
The statement supports coordinated investigation, specimen tracking, and later after-action reviews.

Essential sections to include in a professional statement

A complete Healthcare Bioterrorism Statement should include discrete, verifiable sections to support clinical, legal, and public health needs.

Incident Summary

Clear, time-stamped description of the event, including location and immediate actions taken; this anchors the record for responders and investigators.

Patient Information

Accurate identifiers and demographic data to enable linkage with medical records, laboratory results, and contact tracing activities.

Clinical Findings

Objective signs, symptoms, diagnostic tests, and treatments administered with timestamps to support clinical and epidemiologic analysis.

Exposure Assessment

Assessment of likely exposure routes and affected populations with a concise rationale for the chosen exposure level.

Data Sharing Consent

Statements about permitted disclosures to public health and other agencies; note any patient-authorized limits on sharing.

Authentication

Signature block with signer role, contact, and an audit trail showing method of identification and time of signing.

Practical tips for accurate and efficient completion

Small practices in form completion reduce errors and support rapid public health coordination.

Use standardized date and time formats

Always enter dates as MM/DD/YYYY and use 24-hour time where possible so exposure windows and lab timelines are unambiguous during investigation.

Verify legal and facility names

Confirm facility legal name and department to ensure jurisdictional routing and correct agency notification for public health reporting.

Employ strong signer authentication

Use multi-factor or identity-proofing for certifiers when possible to strengthen attribution and reduce questions about signature validity.

Preserve the audit trail and originals

Keep an immutable audit trail, exported signed PDF/A, and chain-of-custody documentation for any specimens associated with the incident.

Typical eSignature platform price and feature comparison

Cost and capability vary across providers; the table below shows starting price and selected features to consider for secure healthcare attestations.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by promotion	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

FAQs: common questions about the Healthcare Bioterrorism Statement

Answers to frequent questions about legality, HIPAA handling, signatures, notarization, retention, and corrections.

Need help? Contact support

Is an electronic signature legally valid?
Yes. Electronic signatures are legally valid for most interstate and intrastate transactions under the ESIGN Act (15 U.S.C. §7001) and state UETA statutes, provided intent, consent, attribution, and record retention requirements are met.
How should PHI be protected when submitting?
Handle protected health information in compliance with HIPAA. Use a vendor that supports HIPAA and signs a Business Associate Agreement; retain access logs and limit recipients to authorized public health or internal staff.
Who is authorized to sign the statement?
A clinically responsible party or designated administrative officer typically signs. Authority should be defined by facility policy; document the signer role, printed name, and contact information for verification.
When is notarization or RON required?
Notarization is rarely required for routine incident reporting but may be requested for formal certifications. RON availability and acceptance vary by state; consult the state notary commission for specific rules.
How long must the statement be retained?
Retain records according to applicable laws. HIPAA-regulated documents should be kept for six years from creation or last effective date (45 CFR §164.530(j)); other statutes may require different periods.
What if I discover an error after signing?
Correct errors using an amended statement that references the original signed document. Preserve the original, include an auditable amendment, and notify public health or legal counsel if the correction affects reporting.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now